Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines

BNT162b2 (BioNTech/Pfizer) was the first SARS-CoV-2 mRNA vaccine approved by the European Medicines Agency. We monitored the long-term humoral responses of healthcare workers (HCWs) who received three vaccine doses. A total of 59 healthcare workers were studied: 47 were never SARS-CoV-2-infected (na...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Roberta, Agostini, Simone, Citterio, Lorenzo Agostino, Chiarini, Debora, Santangelo, Maria Antonia, Clerici, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610882/
https://www.ncbi.nlm.nih.gov/pubmed/36298514
http://dx.doi.org/10.3390/vaccines10101649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610882/
https://www.ncbi.nlm.nih.gov/pubmed/36298514
http://dx.doi.org/10.3390/vaccines10101649

Ejemplares similares